Browse the evidence

Daily moderate alcohol consumption (25g ethanol) for 6 weeks improves insulin sensitivity and increases adiponectin levels in postmenopausal women.

For postmenopausal women who already drink moderately, continuing to consume about one standard drink (25g alcohol) daily with dinner may support insulin sensitivity and healthy adiponectin levels. This does not mean non-drinkers should start drinking, as the risks of alcohol outweigh these specific metabolic benefits for most people.

Human obesity is primarily driven by the interaction of ancestral energy-conserving genetic adaptations (thrifty genotype) with a modern environment of energy abundance and physical inactivity.

Understand that your body is biologically wired to store fat efficiently because of your evolutionary history. In a modern world with abundant food and low activity, this wiring promotes weight gain. This is not a moral failing but a biological reality. Management requires acknowledging this mismatch and structuring your environment (food access, activity levels) to counteract these ancestral drives.

Captive primates and wild primates with access to abundant, low-effort food sources (like garbage) develop obesity and metabolic abnormalities, demonstrating that energy storage capacity exists in primates when foraging costs are removed.

Your body's ability to store fat is a survival mechanism. When you reduce physical activity (like sitting at a desk) and have easy access to food, your body will store that energy as fat, just as it does in captive primates. To manage weight, you must either increase energy expenditure or restrict energy intake to match your lower activity level.

Chronic psychological or physical stress induces hypercortisolism, which promotes visceral adiposity and metabolic syndrome by inhibiting lipolysis and stimulating lipogenesis via glucocorticoid receptors.

If you carry weight around your midsection (visceral fat) and feel chronically stressed, your body may be biologically programmed to store fat there due to high cortisol levels. This is not just 'willpower'; cortisol directly blocks fat burning (lipolysis) and encourages fat storage (lipogenesis) in the abdomen. Addressing chronic stress through behavioral or physiological means is a critical component of managing visceral obesity and metabolic health, alongside diet and exercise.

Chronic stress and hypercortisolism inhibit the growth hormone (GH) axis and sex steroid production, which further promotes visceral fat accumulation and insulin resistance.

Long-term stress doesn't just raise cortisol; it also lowers your body's ability to burn fat by suppressing growth hormone and sex hormones like testosterone. This hormonal shift makes it harder to lose visceral fat and easier to gain it, creating a cycle that is difficult to break without addressing the underlying stress.

Government policies such as traffic light labeling, import duties on unhealthy foods, and promoting local produce are effective strategies to limit obesity.

Advocate for or support policies that make healthy food more accessible and affordable, such as traffic light labeling and subsidies for local produce.

Targeted ablation of glucose-dependent insulinotropic polypeptide (GIP)-producing K cells in mice prevents high-fat diet-induced obesity and insulin resistance by reducing body weight, decreasing food intake, and increasing energy expenditure.

This preclinical study suggests that blocking the action of GIP-producing cells in the gut can protect against obesity and insulin resistance caused by a high-fat diet. The mechanism involves reduced food intake and increased energy expenditure. While this is not a human intervention, it highlights GIP as a potential therapeutic target for obesity.

Obesity is associated with delayed cancer diagnosis and reduced treatment efficacy due to screening biases, technical challenges, and altered drug metabolism.

If you are obese, be proactive about your cancer screening. Inform your provider about your weight so they can use appropriate equipment and techniques. Ensure you receive full doses of chemotherapy and radiation, as obesity can sometimes lead to undertreatment. Advocate for yourself to ensure you get the standard of care.

Liver-derived extracellular vesicles (EVs) containing specific miRNAs (let-7e-5p, miR-210-3p, miR-31-5p) are secreted in response to lipid overload and directly target adipocytes to promote adipogenesis and lipogenesis, thereby remodeling adipose tissue.

This research highlights that liver health directly influences fat storage through biological signaling, not just caloric balance. While this doesn't provide a direct lifestyle fix, it suggests that improving liver metabolic health (e.g., reducing lipid overload) may naturally reduce the drive for adipose tissue expansion.

Geranylgeranyl diphosphate synthase (Ggpps) in the liver is required for the secretion of lipid-overload-responsive EVs; liver-specific deletion of Ggpps reduces adipose mass and improves glucose tolerance.

This identifies Ggpps as a key enzyme controlling liver-to-fat signaling. Future therapies might target Ggpps to modulate fat storage, but currently, maintaining liver health through diet is the primary way to manage this pathway.

In obese youth, gut microbiota exhibit a higher capability to ferment carbohydrates into short-chain fatty acids (SCFAs) compared to lean youth, and these SCFAs serve as substrates for hepatic de novo lipogenesis (DNL), thereby increasing energy harvest and fat partitioning.

For obese youth, the gut microbiome may extract more energy from carbohydrates than in lean individuals by converting them into short-chain fatty acids (SCFAs) like acetate and butyrate. These SCFAs are then used by the liver to create new fat (DNL). Simply eating 'healthy' carbs might not be enough if the gut microbiome is highly efficient at fermentation; the resulting SCFAs fuel fat storage. This suggests that interventions might need to target gut microbiota composition or fermentation rates, not just caloric intake.

Simulated night-shift work induces 24-hour rhythms in circulating metabolites (including amino acids and lipids) that are driven by externally imposed behavioral time cues (sleep/wake, feeding/fasting) rather than the central suprachiasmatic nuclei (SCN) circadian pacemaker.

If you work night shifts, your body's metabolic rhythms (how it processes fats and proteins) are likely shifting to match your sleep and eating schedule, not your internal biological clock. This misalignment is a key driver of metabolic risk. To mitigate this, consider aligning your eating windows strictly with your awake hours (time-restricted feeding) and maintaining consistent sleep schedules, as these behavioral cues strongly influence peripheral metabolism.

Current food fortification and dietary supplement programs in the Middle East are sporadic and ineffective, failing to address the high prevalence of micronutrient deficiencies.

Do not rely solely on government food fortification to meet your micronutrient needs, as these programs are inconsistent in the region. You may need to take dietary supplements and get regular blood tests to ensure you are meeting your requirements for vitamins and minerals.

Supplementation with NAD+ intermediates (NMN or NR) restores declining NAD+ levels in aged animals, thereby reversing age-associated metabolic dysfunction, improving mitochondrial function, and extending healthspan.

Aging is associated with a measurable drop in cellular NAD+, which impairs energy metabolism and mitochondrial function. Supplementing with precursors like Nicotinamide Mononucleotide (NMN) or Nicotinamide Riboside (NR) can restore NAD+ levels. In animal studies, this restoration reverses metabolic dysfunction, improves energy expenditure, and enhances physical activity, suggesting a viable strategy to mitigate age-related decline.

Epigenetic modifications, particularly DNA methylation patterns, serve as accurate biomarkers of biological age and are influenced by both genetic background and lifestyle.

Use epigenetic testing to monitor your biological age. This can help you assess the effectiveness of your lifestyle interventions and track your progress in extending healthspan.

Post-nutritional transition obesity trends exhibit a 'plateau' or stabilization phase after initial rapid rise, making subsequent reduction extremely difficult and requiring highly intensive, comprehensive state-level interventions rather than standard health promotion.

If you are trying to manage weight in a society where obesity has stabilized at high levels, individual effort alone is likely insufficient. You must advocate for and leverage comprehensive environmental changes, such as stricter food marketing regulations and increased access to physical activity, as these are necessary to overcome the 'plateau' effect.

Intracellular regulation of thyroid hormone by deiodinases (D1, D2, D3) dictates tissue-specific metabolic outcomes, where local T3 activation promotes energy expenditure and lipid mobilization, while inactivation preserves energy stores.

Your body's metabolic rate isn't just determined by your thyroid gland's output, but by how your specific tissues process that hormone. Enzymes called deiodinases activate or deactivate thyroid hormone locally in organs like muscle and fat. This means two people with identical blood thyroid levels can have vastly different metabolic rates and fat storage tendencies depending on their tissue-specific enzyme activity.

Brown Adipose Tissue (BAT) activity and adaptive thermogenesis are critically dependent on local Type 2 Deiodinase (D2) activity converting T4 to T3, particularly in response to cold exposure.

Exposure to cold can activate Brown Adipose Tissue (BAT), which burns calories to generate heat. This process relies on local thyroid hormone activation by the enzyme D2. While this is a potent metabolic lever, its impact varies significantly between individuals based on the amount of active BAT they possess.

Type 3 Deiodinase (D3) inactivation of thyroid hormone is essential for pancreatic beta-cell maturation and insulin secretion; D3 deficiency leads to glucose intolerance and impaired insulin secretion.

Proper regulation of thyroid hormone inactivation (by D3) in the pancreas is crucial for normal insulin secretion. Disruption of this local balance can impair beta-cell function and contribute to glucose intolerance, independent of systemic thyroid status.

Morbidly obese women exhibit significantly lower striatal dopamine D2/3 receptor availability compared to non-obese controls, suggesting a hypodopaminergic state that may drive compulsive eating.

This research suggests that obesity in some individuals may be linked to a biological difference in brain reward systems (specifically lower dopamine receptors), which can make food feel less rewarding and drive compulsive eating. This is not a moral failing but a neurochemical factor. While this doesn't provide a direct 'fix,' it highlights why standard willpower-based approaches might fail for some and suggests that treatments addressing brain reward pathways could be beneficial.

Systemic nonselective beta-adrenergic stimulation via isoprenaline increases whole-body energy expenditure to levels comparable to cold exposure but does not activate brown adipose tissue (BAT) in humans.

Taking beta-agonists to boost metabolism via brown fat activation is likely ineffective in humans. While these drugs do increase calorie burning, they do so through other tissues (like skeletal muscle), not brown fat. Strategies relying on beta-agonists to target brown fat specifically are not supported by this evidence.

Persons with chronic spinal cord injury, particularly those with tetraplegia and complete lesions, have significantly lower physical activity levels than able-bodied individuals, contributing to obesity.

Standard daily tasks like pressure relief and bowel programs are sedentary and do not burn significant calories. To prevent obesity, you must engage in structured physical activity (exercise) to increase your total daily energy expenditure.

Resting metabolic rate (RMR) in SCI patients is lower than in able-bodied individuals, but this difference is largely explained by reduced fat-free mass and altered sympathetic nervous system activity, not by an inherent inefficiency of fat-free tissue.

Your lower resting metabolic rate is due to having less muscle mass and altered nerve signaling, not because your cells are inefficient. Focus on maintaining muscle mass and accurate calorie intake rather than assuming your metabolism is 'broken'.

Normal human aging is characterized by a significant increase in mean daily serum cortisol levels and a decrease in DHEA, leading to an elevated cortisol-to-DHEA ratio that impairs stress recovery and accelerates neurodegeneration.

As you age, your body naturally produces more cortisol (stress hormone) and less DHEA (anti-aging hormone). This imbalance impairs your ability to recover from stress and increases the risk of cognitive decline, muscle loss, and metabolic issues. Managing stress and maintaining physical activity are critical to mitigating these hormonal shifts.